<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC3228724/results/search/funders/results.xml">
  <result pre="Saranchuk Peter 2 Rodrigues Camilla 7 Reid Tony 8 [1]," exact="Médecins Sans Frontières," post="Mumbai, India [2], Médecins Sans Frontières, Cape Town, South"/>
  <result pre="Reid Tony 8 [1], Médecins Sans Frontières, Mumbai, India [2]," exact="Médecins Sans Frontières," post="Cape Town, South Africa [3], Monash University, Melbourne, Australia"/>
  <result pre="India [2], Médecins Sans Frontières, Cape Town, South Africa [3]," exact="Monash University," post="Melbourne, Australia [4], Hygiene and Preventive Medicine Institute, University"/>
  <result pre="Institute, University of Sassari, Sassari, Italy [5], S. Maugeri Foundation," exact="World Health Organization" post="Collaborating Centre for Tuberculosis and Lung Diseases, Tradate, Italy"/>
  <result pre="National Hospital and Medical Research Centre (Hinduja), Mumbai, India [8]," exact="Médecins Sans Frontières," post="Operational Research Unit, Brussels, Belgium Kranzer Katharina Editor [],"/>
  <result pre="treatment for MDR-TB is extremely limited, particularly for HIV-infected individuals." exact="Médecins Sans Frontières" post="(MSF) has been treating HIV-infected MDR-TB patients in Mumbai"/>
  <result pre="and treatment initiation, particularly among HIV-infected populations. In February 2006," exact="Médecins Sans Frontières" post="(MSF) started an HIV project in Mumbai, offering care"/>
  <result pre="of confirmed or suspected MDR-TB, by clinicians working in the" exact="Ministry of Health" post="and Family Welfare network of ART centers, and by"/>
  <result pre="second-line drugs (kanamycin, ethionamide, para-aminosalicylic acid (PAS) and ofloxacin) using" exact="World Health Organization" post="(WHO) approved guidelines for drug concentrations. Samples were processed"/>
  <result pre="protocol was approved by the Independent Ethics Review Board of" exact="Médecins Sans Frontières," post="Geneva, Switzerland. As this was a study of routinely"/>
  <result pre="out, treatment failure, and ‘alive and on treatment’ [12], [15]." exact="Microsoft" post="Excel and SPSS (version 16.0, Chicago, IL) were used"/>
  <result pre="external funding sources for this study. References References 1 collab:" exact="World Health Organization" post="(WHO) 2010 Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010"/>
  <result pre="N Engl J Med 362 697 706 20181971 12 collab:" exact="World Health Organization" post="(WHO) 2008 Guidelines for the programmatic management of drug-resistant"/>
  <result pre="Southern Africa. PLoS ONE 4 9 e7186 19779624 14 collab:" exact="World Health Organization" post="(WHO) 2010 Antiretroviral therapy for HIV infection in adults"/>
  <result pre="study from Cambodia. BMC Pediatr 9 54 19691853 30 collab:" exact="World Health Organization" post="(WHO) 2009 Management of MDR-TB: a field guide. A"/>
  <result pre="Engl J Med 363 11 1005 15 20825313 32 collab:" exact="World Health Organization" post="(WHO) 2010 Roadmap for rolling out Xpert MTB/RIF for"/>
 </snippets>
</snippetsTree>
